Related Experiment Video
Updated: Jul 17, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Patent foramen ovale and cryptogenic stroke. A critical review
Luigi Ballerini1, Alberta Cifarelli, Antonio Ammirati
1Department of Pediatric Cardiology, Bambino Gesù Hospital, Rome, Italy. ballerini.cifarelli@iol.it
Insights
Patent foramen ovale (PFO) is common in cryptogenic stroke patients. Percutaneous PFO closure is considered for specific cases, showing promise in pediatric stroke prevention.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Cryptogenic stroke in young patients often lacks identifiable causes.
- Patent foramen ovale (PFO) is found in 45% of cryptogenic stroke patients, compared to 25% in healthy individuals.
- Right-to-left shunts through PFO are a suspected mechanism for ischemic cerebral events, potentially via paradoxical embolism.
Purpose of the Study:
- To review the current understanding and indications for percutaneous closure of PFO in cryptogenic stroke.
- To evaluate the safety and efficacy of PFO closure, particularly in specific patient subgroups.
Main Methods:
- Review of existing literature and clinical data on PFO prevalence and its association with stroke.
- Discussion of percutaneous closure techniques and current evidence, including ongoing randomized trials.
- Analysis of outcomes in pediatric populations and specific indications like recurrent paradoxical embolism.
Main Results:
- Percutaneous PFO closure is currently indicated for recurrent paradoxical embolism in patients with atrial septal aneurysm.
- The procedure is considered safe and effective in preventing recurrent stroke in the pediatric population.
- While debated for general cryptogenic stroke, ongoing trials are expected to provide further data.
Conclusions:
- Percutaneous PFO closure is a viable option for specific indications, with growing evidence supporting its use in pediatric stroke.
- The decreasing complication rates of device implantation may lower the threshold for considering PFO closure in broader patient groups.
- Further data from randomized trials are crucial for defining the role of PFO closure in adult cryptogenic stroke management.
Abstract:
The underlying causes of ischemic stroke in young patients are often difficult to find, despite systematic investigations concerning heart, coagulation system or any other type of vascular disease, thus the definition of 'cryptogenic'. In patients with cryptogenic stroke, the prevalence of a patent foramen ovale is about 45%, versus 25% of the general healthy population, leading to many speculations about a potential role of intracardiac right-to-left shunts in determining ischemic cerebral disease. Since a possible mechanism has been thought to be paradoxical embolism, percutaneous closure of the foramen ovale is currently discussed, at least until the appearance of data from the ongoing randomized trials. However, recurrent paradoxical embolism in patients with an aneurysmal atrial septum and a patent foramen ovale is currently the only unequivocal indication for percutaneous closure. Professional divers may benefit from the procedure as well, whereas migraine is still not considered an indication. In the pediatric population, closure of the patent foramen ovale seems to be safe and effective to prevent recurrent stroke. As the complication rate for device implantation decreases, the threshold for percutaneous closure is likely to decline.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Hemorrhagic Stroke l: Introduction
Stroke: Introduction and Types
